Welcome to NeoGenomics Pharma Services

We provide unparalleled expertise in collaborating with
our clients on oncology drug development and commercialization.

With NeoGenomics' acquisition of Clarient, NeoGenomics’ Pharma Services division now offers a wider range of service offerings and provide an even higher level of support to our clients. Whether you need a custom assay developed or would like to use one of our clinically validated tests, we can help advance your clinical trial.